05 May 2021 | News
Dozee monitors COVID-19 related vital signs such as respiration rate, heart rate, blood pressure, SPO2 of the user and comes with an early warning system for timely hospital transfers
Dozee has announced the launch of its home monitoring service to continuously monitor mild and asymptomatic COVID-19 patients in the comfort of their homes. Dozee monitors COVID-19 related vital signs such as respiration rate, heart rate, blood pressure, SPO2 of the user and comes with an early warning system for timely hospital transfers.
The service also includes a mobile app for the family members, daily health report for sharing with doctors and 24x7 support to help manage COVID-19 better. The caretakers and the family members get continuous visibility of vital trends and an alert in case of possible health deterioration.
The device is available on a rental model for Rs 3999 for 30 days and Rs 2999 for a 15 day service and customers can book the service directly on Dozee’s website.
Dozee is a contactless sensor sheet when placed under the mattress enables the continuous (more than 100 times per hour) and accurate monitoring of a patient’s heart rate, respiratory rate, and other clinical parameters like sleep apnea, myocardial performance metrics.
Made in India, Dozee has been launched with a 98.4 per cent medical grade accuracy after successful clinical trials conducted with over 1000 subjects at NIMHANS and Sri Jayadeva Institute. Apart from its use at home, Dozee also allows healthcare providers in private & government hospitals to remotely monitor patients’ vital signs, receive updates and deterioration alerts. The solution also includes an integrated early warning system for patients in the post-discharge, outpatient settings and hospital-level home care settings.
Mudit Dandwate, CEO & Co-founder, Dozee stated, “The initial uptake of the home service has been very good and we are glad to be able to help people recover from the comfort of their homes.”